BCM
Bayesian Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,900
| Closed | -$829K | – | 537 |
|
|
2025
Q1 | $829K | Buy |
+37,900
| New | +$829K | 0.14% | 206 |
|
|
2024
Q4 | – | Sell |
-31,200
| Closed | -$900K | – | 678 |
|
|
2024
Q3 | $900K | Buy |
+31,200
| New | +$900K | 0.11% | 262 |
|
|
2024
Q1 | – | Sell |
-17,275
| Closed | -$1.03M | – | 770 |
|
|
2023
Q4 | $1.03M | Buy |
+17,275
| New | +$1.03M | 0.11% | 228 |
|
|
2023
Q3 | – | Sell |
-9,124
| Closed | -$831K | – | 685 |
|
|
2023
Q2 | $831K | Sell |
9,124
-8,800
| -49% | -$802K | 0.09% | 300 |
|
|
2023
Q1 | $1.18M | Buy |
+17,924
| New | +$1.18M | 0.15% | 209 |
|
|
2022
Q3 | – | Sell |
-11,600
| Closed | -$525K | – | 687 |
|
|
2022
Q2 | $525K | Sell |
11,600
-2,400
| -17% | -$109K | 0.1% | 322 |
|
|
2022
Q1 | $711K | Buy |
+14,000
| New | +$711K | 0.11% | 282 |
|